Table 3.
Proportion of GLA:D™ participants with clinically important improvement by program payor, baseline to 3-months (self-reported measures) and from baseline to program completion (physical measures).
| Private (n = 353) | Publicly funded by Alberta Health Servicesa (n = 139) | Publicly funded by a Primary Care Networkb (n = 62) | P-value | |
|---|---|---|---|---|
| Outcomes | Percent (95% Confidence Interval) | |||
| Pain | 11.5 (8.5–15.5) | 12.3 (7.5–19.5) | 27.7 (16.5–42.6 | 0.03 |
| Joint-related quality of life | 24.8 (20.5–29.6) | 28.7 (21.6–36.7) | 22.6 (13.7–35.0) | 0.54 |
| Health-related quality of life | 27.6 (23.2–32.6) | 26.1 (19.3–34.3) | 21.3 (12.6–33.7) | 0.41 |
| 30-s chair stand (count) | 71.3 (65.4–76.5) | 73.0 (63.8–80.5) | 74.5 (59.6–85.2) | 0.32 |
| 40-m walk test (sec) | 75.3 (68.0–81.4) | 78.2 (68.1–85.7) | 77.8 (57.0–90.2) | 0.96 |
a
Publicly funded at outpatient physiotherapy.
b
Publicly funded at community-based primary care centres.